Fulminant hepatic failure. Unusual cardiac failure presentation.

被引:0
|
作者
Ridruejo, E
Laurini, J
Cingolani, O
机构
[1] CEMIC, Dept Med Interna, Secc Clin Med, Buenos Aires, DF, Argentina
[2] CEMIC, Serv Patol, Buenos Aires, DF, Argentina
关键词
heart failure; fulminant liver failure; ischemic liver disease; cardiogenic shock;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Congestive liver disease can be one of the clinical aspects of chronic heart failure. Fulminant hepatic failure can be a consequence of ischemic liver disease secondary to cardiogenic shock. We report a patient with chronic heart failure who was admitted to our hospital presenting general malaise with abnormal liver function tests, prothrombin time and renal failure. The study of viral and autoimmune liver diseases were negative. She did not consume hepatotoxic drugs. She presented encephalopathy without initial evidence of shock. On the fourth day, she presented clinical deterioration compatible with cardiogenic shock. Laboratory abnormalities were similar to those seen in congestive and ischemic liver disease. The patient died 24 hours later. The histology showed congestive and ischemic liver disease. There are several reports of chronic liver diseases without a clear etiology, caused by constrictive pericarditis or restrictive myocardiopathy. In this case, the patient presented fulminant hepatic failure without clear evidence of progressive heart failure. We emphasize the importance of cardiac diseases as possible causes of liver diseases without another clear explanation.
引用
收藏
页码:491 / 494
页数:4
相关论文
共 50 条
  • [31] Fulminant acute liver failure as an unusual presentation of Kawasaki disease
    Anjani, G.
    Deglurkar, R.
    Pilania, R. K.
    Chaudhary, H.
    Vaiphei, K.
    Vignesh, P.
    Singh, S.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2021, 50 (04) : 327 - 329
  • [32] Enhanced expression of chemokines correlates with the infiltration of macrophages in fulminant hepatic failure.
    Leifeld, L
    Purr, I
    Janberg, K
    Dumoulin, FL
    Altfeld, M
    Sauerbruch, T
    Spengler, U
    HEPATOLOGY, 1999, 30 (04) : 547A - 547A
  • [33] Early rejection in fulminant hepatic failure. Our experience with neoral.
    Trigo, PL
    Lendoire, JC
    Braslavsky, GA
    Amante, MF
    Romero, MC
    Imventarza, OC
    HEPATOLOGY, 2001, 34 (04) : 646A - 646A
  • [34] TT-virus infection in Israeli patients with fulminant hepatic failure.
    Safadi, R
    Ergunay, K
    Ilan, Y
    Klein, A
    Shouval, D
    Manny, N
    Harush, N
    Galun, E
    HEPATOLOGY, 1999, 30 (04) : 290A - 290A
  • [35] Bioartificial liver treatment of acetaminophen-induced fulminant hepatic failure.
    Ting, P
    Detry, O
    Arkadopoulos, N
    Kahaku, E
    Watanabe, FD
    Rozga, J
    Mullon, CJP
    Demetriou, AA
    HEPATOLOGY, 1998, 28 (04) : 394A - 394A
  • [36] Circulating concentrations of CXC chemokines in acetaminophen induced fulminant hepatic failure.
    Mohamed, HH
    Hogaboam, CM
    Lukacs, NW
    Bone-Larson, CL
    Hayes, PC
    Colliti, LM
    Strieter, RM
    Kunkel, SL
    Simpson, KJ
    HEPATOLOGY, 2000, 32 (04) : 201A - 201A
  • [37] Fulminant hepatic failure
    Sass, DA
    Shakil, AO
    LIVER TRANSPLANTATION, 2005, 11 (06) : 594 - 605
  • [38] Fulminant hepatic failure
    Shakil, AO
    Mazariegos, GV
    Kramer, DJ
    SURGICAL CLINICS OF NORTH AMERICA, 1999, 79 (01) : 77 - +
  • [39] Fulminant hepatic failure
    Kurtovic J.
    Riordan S.M.
    Williams R.
    Current Treatment Options in Gastroenterology, 2005, 8 (6) : 503 - 518
  • [40] FULMINANT HEPATIC FAILURE
    HUSSEY, HH
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1973, 226 (10): : 1227 - 1227